Two industry leaders have been appointed partners at early-stage venture capital firm Boundary Capital. Dr Adrian Parton MBE and Grant Hawthorne are both key influencers in their respective fields of biotechnology and investment.

The appointments mark an increase in UK investments made by Boundary Capital in 2015 and the launch of their new SEIS fund AngelPlus.

Serial biotech entrepreneur Dr Adrian Parton MBE has successfully grown and sold multiple businesses from concept. These include Genera Technologies Ltd, sold in 2000 to Idexx Labs Inc for $17m, food diagnostics firm Matrix MicroScience Ltd, sold to Life Technologies Inc for $20m and Cronto, sold to Vasco Data Security in 2013 for €17m.

Previously manager of one of the UK’s largest business angel networks, Great Eastern Investment Forum, Grant was also part of the management team at Azea Networks, a company that successfully raised $80million and was acquired by Xtera Communications Inc.

Boundary Capital is an early-stage venture capital firm specialising in technology based businesses. They are recognised for their unique investment model of placing an experienced industry expert within their portfolio businesses to enhance and accelerate their growth.

Dan Somers, Managing Partner at Boundary Capital says: “Through these exciting appointments we are strengthening our presence in both the biotech and generalist arena as well as supporting the continuous growth of Boundary Capital.”

Write a comment:

*

Your email address will not be published.

Boundary Capital Partners LLP is authorised and regulated by the Financial Conduct Authority.
Boundary Capital Partners LLP Reg: OC387581 VAT: 204012873
Registered office: 35 Kingsland Road, London, England, E2 8AA

STAY CONNECTED WITH US: